235 related articles for article (PubMed ID: 9564534)
1. Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: new tool for gene transfer studies and gene therapy.
Loimas S; Wahlfors J; Jänne J
Biotechniques; 1998 Apr; 24(4):614-8. PubMed ID: 9564534
[TBL] [Abstract][Full Text] [Related]
2. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
3. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
4. Generation of fusion genes carrying drug resistance, green fluorescent protein, and herpes simplex virus thymidine kinase genes in a single cistron.
Oh SC; Nam SY; Kwon HC; Kim CM; Seo JS; Seong RH; Jang YJ; Chung YH; Chung HY
Mol Cells; 2001 Apr; 11(2):192-7. PubMed ID: 11355700
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
Uch R; Gérolami R; Faivre J; Hardwigsen J; Mathieu S; Mannoni P; Bagnis C
Cancer Gene Ther; 2003 Sep; 10(9):689-95. PubMed ID: 12944988
[TBL] [Abstract][Full Text] [Related]
6. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.
Jacobs A; Dubrovin M; Hewett J; Sena-Esteves M; Tan CW; Slack M; Sadelain M; Breakefield XO; Tjuvajev JG
Neoplasia; 1999 Jun; 1(2):154-61. PubMed ID: 10933050
[TBL] [Abstract][Full Text] [Related]
7. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
Candotti F; Agbaria R; Mullen CA; Touraine R; Balzarini J; Johns DG; Blaese RM
Cancer Gene Ther; 2000 Apr; 7(4):574-80. PubMed ID: 10811475
[TBL] [Abstract][Full Text] [Related]
8. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
Koshikawa N; Takenaga K; Tagawa M; Sakiyama S
Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440
[TBL] [Abstract][Full Text] [Related]
10. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
11. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.
Ponomarev V; Doubrovin M; Serganova I; Beresten T; Vider J; Shavrin A; Ageyeva L; Balatoni J; Blasberg R; Tjuvajev JG
Neoplasia; 2003; 5(3):245-54. PubMed ID: 12869307
[TBL] [Abstract][Full Text] [Related]
13. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy.
Steffens S; Frank S; Fischer U; Heuser C; Meyer KL; Dobberstein KU; Rainov NG; Kramm CM
Cancer Gene Ther; 2000 May; 7(5):806-12. PubMed ID: 10830728
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells.
Shewach DS; Zerbe LK; Hughes TL; Roessler BJ; Breakefield XO; Davidson BL
Cancer Gene Ther; 1994 Jun; 1(2):107-12. PubMed ID: 7621241
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus thymidine kinase enzymatic assay in transient transfection experiments using thymidine kinase-deficient cells.
Jonsson JJ; McIvor RS
Anal Biochem; 1991 Dec; 199(2):232-7. PubMed ID: 1667455
[TBL] [Abstract][Full Text] [Related]
16. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
17. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
18. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity.
Rogulski KR; Kim JH; Kim SH; Freytag SO
Hum Gene Ther; 1997 Jan; 8(1):73-85. PubMed ID: 8989997
[TBL] [Abstract][Full Text] [Related]
19. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
20. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells.
Tang Y; Li J; Zhao S; Liu J
J Int Med Res; 2007; 35(4):433-41. PubMed ID: 17697519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
